Susquehanna Fundamental Investments, LLC Akero Therapeutics, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 8,390 shares of AKRO stock, worth $412,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,390Holding current value
$412,116% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$362 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$337 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$296 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$274 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$257 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.28B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...